Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools

Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies

(2017) Alla G. Wernicke et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties

(2016) Pavel Šácha et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy

(2016) U. Haberkorn et al.   CLINICAL CANCER RESEARCH

PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617

(2016) C. Kratochwil et al.   JOURNAL OF NUCLEAR MEDICINE

PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

(2016) Steven P. Rowe et al.   MOLECULAR IMAGING AND BIOLOGY

Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617

(2016) Melanie Hohberg et al.   MOLECULAR IMAGING AND BIOLOGY

Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)

(2016) Cyril Barinka et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen

(2015) Sangeeta Ray Banerjee et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

[18F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)

(2015) Xing Yang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

(2015) A. P. Kiess et al.   JOURNAL OF NUCLEAR MEDICINE

Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues

(2015) C. Zhu et al.   MOLECULAR CANCER THERAPEUTICS

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies

(2014) F Huber et al.   BRITISH JOURNAL OF CANCER

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen

(2014) Justin P Dassie et al.   MOLECULAR THERAPY

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody

(2014) Stefan Wiehr et al.   PROSTATE

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA)

(2014) J. Tykvart et al.   PROSTATE

Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)

(2014) Florian Kampmeier et al.   EJNMMI Research

Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

(2013) S. T. Tagawa et al.   CLINICAL CANCER RESEARCH

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer

(2013) Scott T. Tagawa et al.   Frontiers in Oncology

GCPII Imaging and Cancer

(2012) C. A. Foss et al.   CURRENT MEDICINAL CHEMISTRY

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

(2012) C. Barinka et al.   CURRENT MEDICINAL CHEMISTRY

Prostate-specific membrane antigen-based imaging

(2012) Joseph R. Osborne et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-Specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody–Indocyanine Green (ICG) Conjugate

(2011) Takahito Nakajima et al.   BIOCONJUGATE CHEMISTRY

Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: Expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II

(2011) J. Tykvart et al.   PROTEIN EXPRESSION AND PURIFICATION

Radionuclide carriers for targeting of cancer

(2010) Stavroula Sofou   International Journal of Nanomedicine

Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer

(2010) Rodney J. Ellis et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo

(2010) J. P. Holland et al.   JOURNAL OF NUCLEAR MEDICINE

Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer

(2009) Kirsten Bouchelouche et al.   CURRENT OPINION IN ONCOLOGY

Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III

(2009) Klara Hlouchova et al.   FEBS Journal

Prostate-specific membrane antigen expression in regeneration and repair

(2008) Ilyssa O Gordon et al.   MODERN PATHOLOGY